• KOL
    • Blood Pressure
    • Alberto Zanchetti
    • Alberto Zanchetti: Influence Statistics

      Alberto Zanchetti

      Alberto Zanchetti

      Show email address

      Istituto Auxologico Italiano, IRCCS, and Università degli Studi of Milan, Italy. | Centro di Fisiologia Clinica e Ipertensione, Università degli Studi di Milano, Milan, Italy ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Alberto Zanchetti:Expert Impact

      Concepts for whichAlberto Zanchettihas direct influence:Blood pressure,Hypertensive patients,Essential hypertension,Ventricular hypertrophy,Metabolic syndrome,Antihypertensive treatment,Renin release,Cardiovascular risk.

      Alberto Zanchetti:KOL impact

      Concepts related to the work of other authors for whichfor which Alberto Zanchetti has influence:Blood pressure,Hypertensive patients,Cardiovascular disease,Metabolic syndrome,Heart rate,Arterial stiffness,Resistant hypertension.

      KOL Resume for Alberto Zanchetti

      Year
      2019

      Istituto Auxologico Italiano, IRCCS, and Università degli Studi of Milan, Italy.

      Centro di Fisiologia Clinica e Ipertensione, Università degli Studi di Milano, Milan, Italy

      2018

      The Istituto Auxologico Italiano, Milan, Italy

      Istituto Auxologico Italiano IRCCS, Scientific Direction.

      2017

      Istituto Auxologico Italiano, Centro Interuniversitario di Fisiologia Clinica e Ipertensione, University of Milan, Italia.

      2016

      Centro di Fisiologia Clinica e Ipertensione, Università degli Studi di Milano, Italy

      University of Alabama at Birmingham, Birmingham, AL, USA

      Istituto Auxologico Italiano, Milan, ITALY

      2015

      Istituto Auxologico Italiano IRCCS and Centro Interuniversitario di Fisiologia Clinica e Ipertensione, University of Milan , Via L. Ariosto, 13, I-20145 Milano , Italy +39 02 619112237 ; +39 02 619112901 ;

      University of Milan and Instituto Auxologico Italiano, Milan, Italy

      2014

      Centro Fisiologia Clinica e Ipertensione, University of Milan, and Istituto Auxologico Italiano, Milan, Italy

      Author affiliations are listed on the Journal website, http://links.lww.com/HJH/A366

      Instituto Auxológico Italiano, Milão, Itália

      2013

      University of Milan, Milan, Italy

      Italia

      2012

      Centro di Fisiologia Clinica e Ipertensione Università di Milano and Istituto Auxologico Italiano, Milan, Italy

      2011

      From the Istituto Auxologico Italiano and the University of Milan, Milan, Italy.

      Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Università di Milano and Istituto Auxologico Italiano, Milan, Italy

      2010

      Centre of Clinical Physiology and Hypertension, University of Milan, Milan

      Centro Interuniversitario de Fisiología Clínica e Hipertensión, Universidad de Milán e Instituto Auxologico Italiano, Milán, Italia

      2009

      From Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Università di Milano, Milan, Italy (A.Z.); Istituto Auxologico Italiano, Milan, Italy (A.Z., C.C., G.P.); Institute for Medical Statistics and Epidemiology, Technische Universität München, Munich, Germany (M.H., R.H.); Division of Vascular Ultrasound Research, Wake Forest University School of Medicine, Winston-Salem, NC (G.B., R.T.); and Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie,...

      Centro Interuniversitario di Fisiologia Clinica e Ipertensione, University of Milano, Milano, Italy

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Alberto Zanchetti is among the top experts in the world.
      Concept World rank
      arb 1 #1
      chlorthalidone decrease #1
      reliability cbmmax #1
      hyperuricemia hypokalemia #1
      sinoaortic reflexes #1
      rvwt31 #1
      female heart hypertension #1
      chlorthalidone verapamil #1
      rate thickness #1
      orally administered verapamil #1
      microalbuminuria study population #1
      goals trials #1
      atenolol regimens baseline #1
      subgroup treatment interaction #1
      impact lvh #1
      75 years association #1
      candesartan cardiovascular #1
      cardiovascular events verapamil #1
      dippers monitoring sessions #1
      1 lifestyle #1
      hypertension molecular determinants #1
      treated chinese patients #1
      80 mmhg evidence #1
      imt hypertensive patients #1
      obstculos #1
      chapter release #1
      classes head #1
      24month data #1
      vhas antihypertensive treatment #1
      kidney dysfunction p0001 #1
      noadd #1
      hypotensive renin #1
      egfrckdepi female follow #1
      uae cardiovascular risk #1
      endpoints total cholesterol #1
      125 110 #1
      latin medicine #1
      ventricular mass normotensives #1
      women tchd #1
      abpm recording #1
      ultrasound examination heart #1
      intense lowering #1
      abpm essential hypertension #1
      treated patients clinic #1
      lvmi ventricular losartan #1
      ambulatory carotid arteries #1
      8 weeks manidipine #1
      effects myocardial fibrosis #1
      afferent posture receptors #1
      a24 slope #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Alberto Zanchetti

      KOL-Index: 20288

      BACKGROUND: Daily aspirin reduces the long-term risk of death due to cancer. However, the short-term effect is less certain, especially in women, effects on cancer incidence are largely unknown, and the time course of risk and benefit in primary prevention is unclear. We studied cancer deaths in all trials of daily aspirin versus control and the time course of effects of low-dose aspirin on cancer incidence and other outcomes in trials in primary prevention.

      METHODS: We studied ...

      Known for Cancer Incidence | Daily Aspirin | Vascular Death | Primary Prevention | Reduced Risk
      KOL-Index: 17398

      OBJECTIVE: To compare the effects of the angiotensin II antagonist, losartan, with those of atenolol on left ventricular hypertrophy (LVH), blood pressure and neurohormone concentrations in hypertensive patients with LVH.

      DESIGN: A multinational, randomized, double-blind trial.

      SETTING: Hospital.

      PATIENTS: Hypertensive patients with an echocardiographically documented left ventricular mass index (LVMI) 120 g/m(2) (men) or 105 g/m(2) (women).

      INTERVENTIONS: Patients allocated randomly to ...

      Known for Losartan Atenolol | Ventricular Mass | Blood Pressure | Essential Hypertension | 36 Weeks
      KOL-Index: 16416

      BACKGROUND: Despite treatment, there is often a higher incidence of cardiovascular complications in patients with hypertension than in normotensive individuals. Inadequate reduction of their blood pressure is a likely cause, but the optimum target blood pressure is not known. The impact of acetylsalicylic acid (aspirin) has never been investigated in patients with hypertension. We aimed to assess the optimum target diastolic blood pressure and the potential benefit of a low dose of ...

      Known for Acetylsalicylic Acid | Patients Hypertension | Pressure Lowering | Major Cardiovascular Events | Aspirin Blood
      KOL-Index: 15654

      BACKGROUND: In cross-sectional studies, ambulatory blood pressure (ABP) correlates more closely than clinic BP with the organ damage of hypertension. Whether ABP predicts development or regression of organ damage over time better than clinic BP, however, is unknown.

      METHODS AND RESULTS: In 206 essential hypertensive subjects with left ventricular hypertrophy (LVH), we measured clinic supine BP, 24-hour ABP, and left ventricular mass index (LVMI, echocardiography) before and after 12 ...

      Known for Clinic Blood | Ambulatory Monitoring | Ventricular Hypertrophy | Sample Study | Lvh Regression
      KOL-Index: 15340

      OBJECTIVE: The Gubbio Study is an Italian population study measuring risk factors for and incidence of major cardiovascular diseases. This analysis investigates the association of serum uric acid with the incidence of coronary and cardiovascular events.

      METHODS: A population sample of 2469 men and women aged 35-74 years, free from major cardiovascular diseases and in whom serum uric acid was measured in 1983 along with other standard risk factors, were followed up for 6 years and the ...

      Known for Serum Uric Acid | Gubbio Population Study | Cvd Events | Cardiovascular Disease | Chd Incidence
      KOL-Index: 14324

      BACKGROUND: Isolated systolic hypertension occurs in about 15% of people aged 60 years or older. In 1989, the European Working Party on High Blood Pressure in the Elderly investigated whether active treatment could reduce cardiovascular complications of isolated systolic hypertension. Fatal and non-fatal stroke combined was the primary endpoint.

      METHODS: All patients (> 60 years) were initially started on masked placebo. At three run-in visits 1 month apart, their average sitting ...

      Known for Active Treatment | Isolated Systolic Hypertension | Cardiovascular Complications | Patients 60 Years | Mm Hg
      KOL-Index: 14117

      OBJECTIVE: To compare the incidence of stroke and other cardiovascular events in hypertensive patients receiving a low-dose diuretic and low-dose calcium antagonist combination with those receiving low-dose diuretic monotherapy, and assess the effects of a small blood pressure difference at achieved levels lower than those achieved in previous placebo-controlled trials.

      METHODS: The Felodipine Event Reduction (FEVER) trial was an investigator-designed, prospective, multicentre, ...

      Known for Hypertensive Patients | Cardiovascular Events | Controlled Trial | Felodipine Event Reduction | Low Dose
      KOL-Index: 13729

      BACKGROUND: It is unclear whether the carotid intima-media thickness can be influenced by antihypertensive treatment and whether some antihypertensive agents, such as calcium antagonists, may have a greater effect on this parameter than others, such as diuretics. The present paper reports the principal results of the ultrasound substudy of the randomized, prospective, controlled, Verapamil in Hypertension and Atherosclerosis Study (VHAS).

      DESIGN AND METHODS: In 498 hypertensive patients ...

      Known for Carotid Plaques | Mm Patients | Atherosclerosis Study | Media Thickness | Antihypertensive Treatment
      KOL-Index: 13728

      BACKGROUND: The possibility that calcium antagonists exert an anti-atherosclerotic action at least partly independently of the blood-pressure-lowering effect is supported by results of a large number of experimental studies and can now be investigated by quantitative B-mode ultrasound imagining of the carotid artery walls.

      DESIGN: The European Lacidipine Study on Atherosclerosis (ELSA) is a prospective, randomized, double-blind, multinational trial comparing effects of 4-year treatment ...

      Known for Media Thickness | Carotid Intima | Baseline Data | Systolic Blood Pressure | Calcium Antagonists
      KOL-Index: 13467

      BACKGROUND: The cardiac effects of hypertension include a variety of structural changes such as increases in left ventricular mass (LVM) and left atrium (LA) size. Although data on hypertension-induced left ventricular changes are extensive, relatively little information is available on LA size from large-scale studies.

      OBJECTIVE: We sought to assess the prevalence of LA enlargement in a large selected hypertensive population and to determine the relations of LA size to several biologic ...

      Known for Ventricular Geometry | Metabolic Syndrome | Atrial Enlargement | Women Lvh | Essential Hypertension
      KOL-Index: 13349

      This double-blind, multicenter trial compared antihypertensive efficacy, tolerability, and impact on quality of life of manidipine and amlodipine in patients with mild-to-moderate essential hypertension. Patients were randomly assigned to 48 weeks of once-daily manidipine, 10-20 mg, or amlodipine, 5-10 mg. Patients who did not respond to treatment after 12 weeks were also given enalapril, 10-20 mg, for the study's duration. The main efficacy end point was equivalence in sitting systolic ...

      Known for Manidipine Amlodipine | Essential Hypertension | Quality Life | 8 Weeks | Antihypertensive Efficacy
      KOL-Index: 13339

      BACKGROUND AND OBJECTIVES: In 68 randomized controlled trials (RCTs), blood pressure (BP) lowering was obtained by using drugs of different classes. We have investigated whether BP lowering by any of the major drug classes is effective in reducing the cardiovascular outcomes.

      METHODS: A total of 55 RCTs (19,5 267 individuals) were suitable for drug-class meta-analyses. Risk ratios and their 95% confidence intervals of seven fatal and nonfatal outcomes were estimated by a random-effects ...

      Known for Outcome Incidence | Blood Pressure | Major Cardiovascular Events | Antihypertensive Agents | Heart Failure

      Key People For Blood Pressure

      Top KOLs in the world
      #1
      Giuseppe Mancia
      blood pressure heart rate metabolic syndrome
      #2
      Suzanne Oparil
      blood pressure resistant hypertension cardiovascular disease
      #3
      Gianfranco Gianfranco
      blood pressure heart failure european society
      #4
      Alberto Zanchetti
      blood pressure hypertensive patients essential hypertension
      #5
      Jackson T Wright
      blood pressure african americans kidney disease
      #6
      Jan Albert Staessen
      blood pressure systolic hypertension renal denervation

      Istituto Auxologico Italiano, IRCCS, and Università degli Studi of Milan, Italy. | Centro di Fisiologia Clinica e Ipertensione, Università degli Studi di Milano, Milan, Italy | Istituto Auxologico Italiano, IRCCS, Milan, Italy | IRCCS Istituto Auxolo

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.